IPIX — Innovation Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $2.18m
- $2.01m
Annual cashflow statement for Innovation Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -6.65 | -13.9 | -7.04 | -3.17 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.22 | 2.23 | 4.85 | 0.751 | 0.379 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.25 | -0.113 | -0.847 | -0.372 | 0.31 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.33 | -4.16 | -9.49 | -6.28 | -2.11 |
| Capital Expenditures | -0.086 | -0.091 | -0.072 | -0.08 | -0.06 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.04 | 0 | — | -4 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.046 | -0.091 | -0.072 | -4.08 | -0.06 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.53 | 9.69 | 13.7 | 3.97 | -0.123 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.84 | 5.44 | 4.18 | -6.39 | -2.29 |